XML 66 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
12 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2012
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]      
Revenues $ 379 $ 679 $ 716
Cost of revenues (11) (20) (21)
Gross profit 368 659 695
Research and development expenses (24,938) (19,906) (12,685)
Less participation by the Office of the Chief Scientist and other parties 5,396 2,673 3,527
Research and development expenses, net (19,542) (17,233) (9,158)
General and administrative expenses (8,676) (5,649) (6,568)
Operating loss (27,850) (22,223) (15,031)
Financial income, net 918 1,068 237
Net loss $ (26,932) $ (21,155) $ (14,794)
Loss per share:      
Basic and diluted net loss per share $ (0.42) $ (0.38) $ (0.34)
Weighted average number of shares used in computing basic and diluted net loss per share 63,514,405 55,481,357 44,031,866